20080815
 Stent Trial Was Conducted With Proper Procedures   The Wall Street Journal,  Aug 25, 2008  An Aug. 14 story ("Boston Scientific Stent Study Flawed," Marketplace, Aug. 14) raised questions about the statistical methodology used in Boston Scientific's Atlas clinical trial, which evaluated the effectiveness of the Taxus Liberte drug-eluting stent in preventing the re-narrowing of treated coronary lesions.   
